EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,646,000 | +98.7% | 50,000 | +3.3% | 0.94% | +67.2% |
| Q2 2019 | $2,338,000 | -74.3% | 48,400 | -73.1% | 0.56% | -77.0% |
| Q1 2019 | $9,101,000 | +108.1% | 180,156 | +144.1% | 2.46% | +54.2% |
| Q4 2018 | $4,374,000 | +58.9% | 73,793 | +76.5% | 1.59% | +68.8% |
| Q3 2018 | $2,752,000 | -35.3% | 41,799 | -54.3% | 0.94% | -60.7% |
| Q4 2017 | $4,254,000 | +16.5% | 91,533 | +1.4% | 2.40% | +26.7% |
| Q3 2017 | $3,651,000 | – | 90,268 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |